Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1993-1994
Article Abstract:
National reporting systems that include detailed case reports and increased use of vaccines against Hemophilus (H.) influenzae type b (Hib) will be needed to meet the US Public Health Service's goal of eliminating Hib disease in young children by 1996. The incidence of invasive H. influenzae disease dropped 29% according to a national surveillance database, but the number of cases caused by Hib appears to have stabilized between 1993 and 1994. In many cases of H. influenzae disease reported to the CDC, the serotype of the bacterium and the vaccination status of the child were unknown. Many of the children with documented Hib disease were too young to have received the complete vaccination series. Cases of H. influenza reported to national surveillance databases should contain information on the serotype of the bacterium, the vaccination status of the child and the name of the vaccine manufacturer.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1987-1995
Article Abstract:
Much progress has been made in eliminating severe Haemophilus influenzae type b (Hib) disease in young children but more effort is needed. Both a national survey by the CDC and surveys of four geographical locations in the US reveal that the incidence of severe Hib disease dropped 95% to 99% between 1989 and 1995. A vaccine against Hib was introduced in 1987. However, in 1995, 74 children with Hib disease were identified and almost half had never been vaccinated. Vaccinating all preschool children will reduce the transmission of the bacterium, which will protect children who are too young to be vaccinated.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b
Article Abstract:
Research on the vaccine against Hemophilus influenzae type b (Hib) can be applied to other bacteria that have a protective capsule. Hib used to be a common cause of meningitis in children and was usually fatal in the pre-antibiotic era. Even after the introduction of antibiotics, many children died or were permanently injured. Hib has a polysaccharide capsule that protects it from attack by the immune system. The capsule has been used to create a vaccine that has virtually eliminated serious Hib infections in children worldwide.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Severe complications of measles requiring intensive care in infants and young children. Epidemiology, etiology, and clinical features of septic arthritis in children younger than 24 months
- Abstracts: Increasing pneumococcal vaccination rates among patients of a national health-care alliance - United States, 1993